Not being privy to reasons why certain formulary decisions are made is a problem. More transparency in the health insurer decision making process would help consumers.
As CMS establishes itself as an HTA entity, it may consider carving out the HTA function and delegating it to an external entity that can operate as a neutral arbiter.